EYPT: EyePoint Pharmaceuticals Inc Company Profile & Statistics

About

EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA.

Info & Links

CEO

JAY S. DUKER

Headquarters

480 PLEASANT STREET
WATERTOWN, MA 02472, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

121

EyePoint Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

554.87M

Enterprise Value

475.04M

Enterprise Value/EBITDA(ttm)

-3.94

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

11.14

Price to Book(mrq)

1.83

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

91.15%

Operating Margin(ttm)

-226.57%

Profit Margin(ttm)

-238.85%

Return on Equity(ttm)

-43.01%

Return on Invested Capital(ttm)

-43.94%

Return on Assets(ttm)

-31.63%

Income Statement

Revenue(ttm)

45.71M

Revenue Per Share(ttm)

0.67

Gross Profit(ttm)

41.82M

EBITDA(ttm)³

-120.45M

Net Income Available to Common(ttm)

-103.57M

Diluted EPS(ttm)

-2.00

Share Statistics

Beta (5Y Monthly)

1.45

52-Week Change

-55.67%

S&P 500 52-Week Change

27.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

68.25M

Dividend Yield

0.00%

Float⁴

65.02M

% Held by Insiders

4.74%

% Held by Institutions

99.41%

Balance Sheet

Total Cash(mrq)

253.79M

Total Cash Per Share(mrq)

3.72

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.50%

Quick Ratio(mrq)

5.45%

Book Value Per Share(mrq)

4.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.66

Free Cash Flow(ytd)

-94.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

EYPT

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals Inc Profile